<p>Immunogenicity of VLP-VP2 in mice (determination of antibody titers of VLP-VP2 in mice).</p
<p>(A) <b>Orally immunized mice:</b> Groups of mice (n = 10) were orally vaccinated three times on d...
<p>The anti-serum was collected at the first week after the last immunization. Each group has six mi...
<p>BALB/c mice were immunized with recombinant proteins as described in the Materials and Methods. O...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
<p>Antibody titer in mice immunized with rSm22.6 and rSm29 after the third immunization.</p
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Groups of five mice were injected i.p. at weeks 0, 2 and 5, with alum-absorbed antigens: EV71-VLP...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>Experimental groups of mice used in the immunogenicity and protective potential trials of Protein...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>Characterization of the conjugates used in the immunogenicity study in mice.</p
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>Groups of mice were immunized twice with 10mer selectant VLPs or wild-type MS2 VLPs. Serum was ta...
<p>(A) <b>Orally immunized mice:</b> Groups of mice (n = 10) were orally vaccinated three times on d...
<p>The anti-serum was collected at the first week after the last immunization. Each group has six mi...
<p>BALB/c mice were immunized with recombinant proteins as described in the Materials and Methods. O...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>Groups of BALB/c mice (n = 5 per group) were inoculated (100 µl) sub-cutaneously at the base of t...
<p>Antibody titer in mice immunized with rSm22.6 and rSm29 after the third immunization.</p
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Groups of five mice were injected i.p. at weeks 0, 2 and 5, with alum-absorbed antigens: EV71-VLP...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>Experimental groups of mice used in the immunogenicity and protective potential trials of Protein...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>Characterization of the conjugates used in the immunogenicity study in mice.</p
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>Groups of mice were immunized twice with 10mer selectant VLPs or wild-type MS2 VLPs. Serum was ta...
<p>(A) <b>Orally immunized mice:</b> Groups of mice (n = 10) were orally vaccinated three times on d...
<p>The anti-serum was collected at the first week after the last immunization. Each group has six mi...
<p>BALB/c mice were immunized with recombinant proteins as described in the Materials and Methods. O...